Alessandra Mularoni

Medicine & Life Sciences

1. Transplant Recipients 100%
2. Infections 63%
3. polyglucosan 58%
4. Transplants 52%
5. Carbapenem-Resistant Enterobacteriaceae 48%
6. ceftazidime drug combination avibactam 47%
7. carbapenemase 41%
8. Klebsiella pneumoniae 39%
9. beta-Lactamases 38%
10. Liver Transplantation 34%
11. Candidemia 34%
12. Carbapenems 34%
13. Human Herpesvirus 8 32%
14. Urinary Tract Infections 31%
15. Italy 30%
16. Prospective Studies 29%
17. Bacteremia 27%
18. Lactams 27%
19. Echinocandins 26%
20. Propensity Score 25%
21. beta-Glucans 25%
22. Cohort Studies 24%
23. Colistin 24%
24. Transplantation 24%
25. Organ Transplantation 21%
26. Tissue Donors 21%
27. Pneumonia 20%
28. Mortality 20%
29. Candida 20%
30. Enterobacteriaceae Infections 20%
31. Hematologic Neoplasms 20%
32. Therapeutics 20%
33. Microbial Sensitivity Tests 20%
34. Fluconazole 20%
35. Ertapenem 18%
36. Meropenem 18%
37. Population Surveillance 18%
38. Multicenter Studies 17%
39. Fungi 17%
40. Kidney 17%
41. Pneumocystis Pneumonia 17%
42. Mycoses 17%
43. Lung 17%
44. Epidemiology 17%
45. Incidence 16%
46. Kaposi's Sarcoma 15%
47. Yeasts 15%
48. Salvage Therapy 15%
49. Gram-Negative Bacteria 14%
50. Confidence Intervals 13%